SEC Filing Summary: Form 8-K
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Dow Inc. and The Dow Chemical Company on February 3, 2025. The filing serves an administrative purpose to submit specific documents as exhibits to the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, thereby avoiding an increase in the size of the 10-K filing.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding exhibit incorporation and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing notes the restatement and effectiveness of "The Dow Chemical Company Elective Deferral Plan (Post 2004)" as of January 1, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. It strictly addresses the incorporation of exhibits by reference into the upcoming 10-K.
Key Facts for Investor Verification
- Document Purpose: This 8-K is an optional filing used solely to attach exhibits to the 2024 Form 10-K.
- Exhibit 10.9: The Dow Chemical Company Elective Deferral Plan (Post 2004) was restated and became effective on January 1, 2025.
- Exhibit 4.5: Contains a description of securities registered under Section 12 of the Securities Exchange Act of 1934.
- Financial Data: Investors must refer to the separate Form 10-K for the year ended December 31, 2024, for all financial metrics and operational results.